首页> 外文期刊>Clinical transplantation. >Surgical strategies for liver transplantation in the case of portal vein thrombosis--current role of cavoportal hemitransposition and renoportal anastomosis.
【24h】

Surgical strategies for liver transplantation in the case of portal vein thrombosis--current role of cavoportal hemitransposition and renoportal anastomosis.

机译:门静脉血栓形成的肝移植手术策略-腔静脉半置位和肾门静脉吻合的当前作用。

获取原文
获取原文并翻译 | 示例
           

摘要

Portal vein thrombosis (PVT), a common complication of end stage liver disease, is no longer considered a definite contraindication for liver transplantation (LTx). The clinical decision to perform an LTx in the case of PVT depends on the degree of PVT and the experience of the surgeon. Eversion thromboendovenectomy was suggested by most authors as the surgical technique of choice for PVT grade 1, 2, and 3. If PVT obstructs more extended parts of the porto-mesenteric venous circulation, surgical options would include different types of venous jump graft reconstructions or arterialization of the portal vein. Combined liver and small bowel transplantation is another possible alternative. Cavoportal hemitransposition (CPHT) and renoportal anastomosis (RPA) were recently particularly advocated as creative surgical strategies in case of diffuse PVT. In this work, we focus on CPHT and RPA surgical techniques during LTx, which attempts to secure the portal flow to the liver graft in case of pre-existent diffuse PVT. We provide a review of all reported clinical experience at international clinical centers using these techniques. According to our meta-analysis a total of 15 studies were published on this topic between 1996 and 2005. In summary, a total of 56 orthotopic LTx have been performed in 53 patients (28 men, 25 women) combined with either CPHT or RPA, for the purpose of providing the donor graft with adequate inflow. Mean age was 44 yr including two patients who were infants, with the youngest recipient being two yr old. Main indications for LTx were liver cirrhosis caused by viral hepatitis, alcoholic cirrhosis and cryptogenic cirrhosis. CPHT was performed in 46 cases, and RPA in 10 cases. Thirty-five of 53 patients (66%) had surgery previous to LTx. Of these, 13 (37%) patients presented with a history of other previous surgical procedures for decompression of portal hypertension or treatment of associated complications (portocaval shunts, splenectomy, etc). Ascites, renal dysfunction, lower extremityand torso edema and variceal bleeding were dominant post-operative complications after CPHT or RPA noted in 22 cases (41.5%), 18 cases (34%), 17 cases (32%) and 13 cases (24.5%) respectively. Patients' follow-up ranged from two to 48 months. Patients survived [39 (74%)] and patients died [14 (26%)] during the course of observation. Based on the literature, we conclude that the ideal technique to overcome PVT during LTx is still controversial. Short-term follow-up results of both methods are promising, however, long-term results are unknown at present. Furthermore, clinical follow-up and basic experimental work is required to evaluate the influence of systemic venous inflow to the liver graft with respect to long-term liver function and liver regeneration.
机译:门静脉血栓形成(PVT)是终末期肝病的常见并发症,不再被视为肝移植(LTx)的明确禁忌证。在PVT情况下执行LTx的临床决策取决于PVT的程度和外科医生的经验。大多数作者建议将外翻性血栓内膜切除术作为PVT 1、2和3级的首选手术技术。如果PVT阻塞门-肠系膜静脉循环的更多延伸部分,则手术选择将包括不同类型的静脉跳接移植重建或动脉化门静脉。联合肝小肠移植是另一种可能的选择。在弥漫性PVT的情况下,最近特别提倡腔静脉半置位术(CPHT)和肾门静脉吻合术(RPA)作为创造性的手术策略。在这项工作中,我们将重点放在LTx期间的CPHT和RPA手术技术上,该技术试图在已有弥漫性PVT的情况下确保通往肝移植的门静脉血流。我们提供了使用这些技术的国际临床中心所有报告临床经验的综述。根据我们的荟萃分析,在1996年至2005年之间,共发表了15篇关于该主题的研究。总的来说,已对53例(28例男性,25例女性)联合CPHT或RPA进行了56例原位LTx,为了使供体移植物有足够的流入量。平均年龄为44岁,其中包括两名婴儿患者,最年轻的接受者为两岁。 LTx的主要适应症是由病毒性肝炎引起的肝硬化,酒精性肝硬化和隐源性肝硬化。 CPHT手术46例,RPA手术10例。 53名患者中有35名(66%)在LTx之前接受过手术。在这些患者中,有13名(37%)曾有过其他用于门静脉高压减压或相关并发症(门腔分流术,脾切除术等)的手术史。腹水,肾功能不全,下肢,躯干水肿和静脉曲张破裂出血是CPHT或RPA术后的主要并发症,分别为22例(41.5%),18例(34%),17例(32%)和13例(24.5%) ) 分别。患者的随访时间为2至48个月。在观察过程中,患者存活[39(74%)],患者死亡[14(26%)]。根据文献,我们得出结论,在LTx期间克服PVT的理想技术仍存在争议。两种方法的短期随访结果都是有希望的,但是目前尚不清楚长期结果。此外,需要临床随访和基础实验工作来评估全身静脉流入肝移植物中对长期肝功能和肝再生的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号